Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

'Just Say It!' – New Streamlined Guidance Format Coming, FDA's Woodcock Says

Nov 14 2017

• By Derrick Gingery

FDA entrance sign 2016

Related Content

Jenkins' Retirement From US FDA Was Several Years In The Making

Dec 06 2016

Alzheimer's Guidance Coming From US FDA, Part Of Broader OND Reform

Sep 14 2017

US FDA Commits To Meeting With Complex ANDA Sponsors, Works Hard To Avoid It

Oct 24 2017

CDER Director Woodcock Plans Changes To Drug Reviews During OND Transition

Mar 07 2017

Warning Label Final Guidance Recommends Use Of Numeric Adverse Reaction Rates

Oct 12 2011

New ANDA Review Pathways: Should You Be A Priority Or Expedited?

Nov 13 2017

Q&A With US FDA Commissioner Scott Gottlieb

Nov 09 2017

Gottlieb Promotes 'Team' Work For Product Reviews

Nov 03 2017

Additional Topics

United States FDA Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window